GW Pharmaceuticals Plc (GWPH): Price and Financial Metrics


GW Pharmaceuticals Plc (GWPH): $218.96

-0.32 (-0.15%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

GWPH POWR Grades


  • Value is the dimension where GWPH ranks best; there it ranks ahead of 82.86% of US stocks.
  • GWPH's strongest trending metric is Value; it's been moving down over the last 197 days.
  • GWPH ranks lowest in Momentum; there it ranks in the 7th percentile.

GWPH Stock Summary

  • The ratio of debt to operating expenses for Gw Pharmaceuticals Plc is higher than it is for about merely 8.06% of US stocks.
  • Over the past twelve months, GWPH has reported earnings growth of -291.26%, putting it ahead of only 6.88% of US stocks in our set.
  • As for revenue growth, note that GWPH's revenue has grown 42.35% over the past 12 months; that beats the revenue growth of 88.2% of US companies in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Gw Pharmaceuticals Plc are GRUB, TRIP, SRPT, VCYT, and NTRA.
  • GWPH's SEC filings can be seen here. And to visit Gw Pharmaceuticals Plc's official web site, go to www.gwpharm.com.

GWPH Stock Price Chart Interactive Chart >

Price chart for GWPH

GWPH Price/Volume Stats

Current price $218.96 52-week high $219.57
Prev. close $219.28 52-week low $87.07
Day low $218.60 Volume 1,464,900
Day high $219.54 Avg. volume 899,771
50-day MA $216.81 Dividend yield N/A
200-day MA $147.25 Market Cap 6.86B

GW Pharmaceuticals Plc (GWPH) Company Bio


GW Pharmaceuticals plc, a biopharmaceutical company, engages in discovering, developing, and commercializing cannabinoid prescription medicines using botanical extracts derived from the Cannabis plant. It operates through three segments: Commercial, Sativex Research and Development, and Pipeline Research and Development. The company was founded in 1998 and is based in Cambridge, the United Kingdom.


GWPH Latest News Stream


Event/Time News Detail
Loading, please wait...

GWPH Latest Social Stream


Loading social stream, please wait...

View Full GWPH Social Stream

Latest GWPH News From Around the Web

Below are the latest news stories about Gw Pharmaceuticals Plc that investors may wish to consider to help them evaluate GWPH as an investment opportunity.

DraftKings May Be The Next GW Pharmaceuticals

Photo by Scott Olson/Getty Images News via Getty Images By K C Ma and Lucas Juery DraftKings (DKNG) is a leader in the fast-growing US sports betting and iGaming industry. Sports bettors are often “sticky” in terms of the platform they use. DKNG has the most preferred and practical online...

Kwan-Chen Ma on Seeking Alpha | May 11, 2021

New Strong Sell Stocks for May 6th

OYST, CDAY, GWPH, HRTG, and NATI have been added to the Zacks Rank #5 (Strong Sell) List on May 6, 2021

Yahoo | May 6, 2021

Jazz Pharmaceuticals' Acquisition of GW Pharmaceuticals Closes

Jazz Pharmaceuticals (NASDAQ: JAZZ) and GW Pharmaceuticals are now under the same corporate roof. The two companies announced Wednesday that Jazz's acquisition of GW has been completed. In the companies' joint press release, Jazz CEO Bruce Cozadd was quoted as saying that the closing "mark[s] a transformative milestone in creating an innovative, high-growth, global biopharma leader in neuroscience with a worldwide commercial and operational footprint."

Yahoo | May 5, 2021

Jazz Pharma (JAZZ) Q1 Earnings Beat, Sales Miss, Stock Down

Jazz Pharmaceuticals (JAZZ) reports mixed first-quarter 2021 results as earnings beat estimates while sales miss the same. Shares down

Yahoo | May 5, 2021

Jazz Pharmaceuticals Completes Acquisition of GW Pharmaceuticals plc

Jazz Pharmaceuticals (Nasdaq: JAZZ) today announced the completion of its acquisition of GW Pharmaceuticals plc (Nasdaq: GWPH) ("GW"), a leader in the science, development and commercialization of cannabinoid-based prescription medicines.

Yahoo | May 5, 2021

Read More 'GWPH' Stories Here

GWPH Price Returns

1-mo N/A
3-mo 1.79%
6-mo 87.23%
1-year 80.18%
3-year 47.33%
5-year 155.73%
YTD 89.72%
2020 10.38%
2019 7.36%
2018 -26.23%
2017 18.13%
2016 60.93%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.874 seconds.